- Home
- ARGX vs ROL Comparison
ARGX vs ROL Comparison
Compare ARGX & ROL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARGX
- ROL
- Stock Information
- Founded
- ARGX 2008
- ROL 1948
- Country
- ARGX Netherlands
- ROL United States
- Employees
- ARGX N/A
- ROL N/A
- Industry
- ARGX Biotechnology: Biological Products (No Diagnostic Substances)
- ROL Diversified Commercial Services
- Sector
- ARGX Health Care
- ROL Finance
- Exchange
- ARGX Nasdaq
- ROL Nasdaq
- Market Cap
- ARGX 40.4B
- ROL 24.9B
- IPO Year
- ARGX 2017
- ROL N/A
- Fundamental
- Price
- ARGX $613.18
- ROL $51.65
- Analyst Decision
- ARGX Strong Buy
- ROL Hold
- Analyst Count
- ARGX 20
- ROL 6
- Target Price
- ARGX $657.83
- ROL $52.00
- AVG Volume (30 Days)
- ARGX 250.2K
- ROL 1.9M
- Earning Date
- ARGX 02-27-2025
- ROL 04-23-2025
- Dividend Yield
- ARGX N/A
- ROL 1.28%
- EPS Growth
- ARGX N/A
- ROL 8.14
- EPS
- ARGX 12.78
- ROL 0.96
- Revenue
- ARGX $2,252,039,000.00
- ROL $3,388,708,000.00
- Revenue This Year
- ARGX $73.81
- ROL $10.01
- Revenue Next Year
- ARGX $56.83
- ROL $8.02
- P/E Ratio
- ARGX $45.67
- ROL $53.78
- Revenue Growth
- ARGX 77.52
- ROL 10.26
- 52 Week Low
- ARGX $349.86
- ROL $41.72
- 52 Week High
- ARGX $678.21
- ROL $53.72
- Technical
- Relative Strength Index (RSI)
- ARGX 38.51
- ROL 66.30
- Support Level
- ARGX $618.21
- ROL $50.85
- Resistance Level
- ARGX $642.24
- ROL $53.72
- Average True Range (ATR)
- ARGX 15.37
- ROL 1.05
- MACD
- ARGX -2.02
- ROL 0.10
- Stochastic Oscillator
- ARGX 7.91
- ROL 71.54
About ARGX argenx SE
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.
About ROL Rollins Inc.
Rollins is a global leader in route-based pest-control services, with operations spanning North, Central and South America, Europe, the Middle East and Africa and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, market leader in the US, where it boasts near national coverage, and in Canada. Residential pest and termite prevention dominates the services provided by Rollins, owing to the group's ongoing focus on US and Canadian markets.